2015 CPT Code Update Effective: January 1, Modified 12/31/2014: CPT has been discontinued.
|
|
|
- Janice Dalton
- 7 years ago
- Views:
Transcription
1 0010B Acecainide, Blood U 2 Butoxyethanol Metabolite (2 Butoxyacetic Acid Total), Urine B Acebutolol, Blood 0012SP Acebutolol, Serum/Plasma 0013SP Acamprosate, Serum/Plasma 0017B Acepromazine, Blood SP Acepromazine, Serum/Plasma U Acepromazine, Urine B Acetaldehyde, Blood SP Acetaldehyde, Serum/Plasma U Acetaldehyde, Urine B Acetaminophen, Blood FL Acetaminophen, Fluid SP Acetaminophen, Serum/Plasma TI Acetaminophen, Tissue 82003, U Acetaminophen, Urine B Acetaminophen Screen, Blood SP Acetaminophen Screen, Serum/Plasma U Acetaminophen Screen, Urine B Acetazolamide, Blood SP Acetazolamide, Serum/Plasma U Acetazolamide, Urine SP Acetohexamide, Serum/Plasma B Acetone, Blood FL Acetone, Fluid SP Acetone, Serum/Plasma U Acetone, Urine B Acetonitrile Exposure Profile, Blood 82600, , B Acetophenazine, Blood SP Acetophenazine, Serum/Plasma B Acrylonitrile Exposure Profile, Blood 84600, , SP Acyclovir, Serum/Plasma 0158U Acyclovir, Urine 0165B Albuterol, Blood 0165FL Albuterol, Fluid 0165SP Albuterol, Serum/Plasma Page 1 of 154
2 0165TI Albuterol, Tissue 83789, B Acyclovir, Blood 0169B Alcohol Screen, Blood (CSA) 80102, , B Alcohol Panel, Blood FL Alcohol Panel, Fluid SP Alcohol Panel, Serum/Plasma TI Alcohol Panel, Tissue 82055, U Alcohol Panel, Urine B Alcohol Screen, Blood FL Alcohol Screen, Fluid SP Alcohol Screen, Serum/Plasma TI Alcohol Screen, Tissue 80101, U Alcohol Screen, Urine B Alcohol (Police), Blood 80102, , SP Alcohol (Police), Serum/Plasma 80102, , U Alcohol (Police), Urine 80102, , B Alcohol, Blood 80102, , SP Alcohol, Serum/Plasma 80102, , U Alcohol, Urine 80102, , B Alcohol, with Statement of Certainty (Police), Blood 80102, , B Alfentanil, Blood SP Alfentanil, Serum/Plasma B Acetyl Fentanyl, Blood SP Acetyl Fentanyl, Serum/Plasma U Acetyl Fentanyl, Urine SP Allobarbital, Serum/Plasma B Allopurinol and Metabolite, Blood SP Allopurinol and Metabolite, Serum/Plasma B Alpha PVP, Blood SP Alpha PVP, Serum/Plasma U Alpha PVP, Urine B Alprazolam, Blood FL Alprazolam, Fluid SP Alprazolam, Serum/Plasma TI Alprazolam, Tissue 80154, B Amantadine, Blood Page 2 of 154
3 0265FL Amantadine, Fluid SP Amantadine, Serum/Plasma U Amantadine, Urine B Amiloride, Blood SP Amiloride, Serum/Plasma B Aminobenzoic Acid, Blood SP Aminobenzoic Acid, Serum/Plasma SP Aminocaproic Acid, Serum/Plasma SP Dalfampridine, Serum/Plasma 0275U Dalfampridine, Urine 0278B DMAA, Blood SP DMAA, Serum/Plasma U DMAA, Urine B Amiodarone and Metabolite, Blood 0307SP Amiodarone and Metabolite, Serum/Plasma 0310B Amitriptyline and Metabolite, Blood FL Amitriptyline and Metabolite, Fluid SP Amitriptyline and Metabolite, Serum/Plasma TI Amitriptyline and Metabolite, Tissue 80152, U Amitriptyline and Metabolite, Urine B Amlodipine, Blood SP Amlodipine, Serum/Plasma SP Amobarbital, Serum/Plasma U Amobarbital, Urine B Amoxapine and Metabolite, Blood SP Amoxapine and Metabolite, Serum/Plasma U Amoxapine and Metabolite, Urine B Amphetamines (D/L Ratio), Blood FL Amphetamines (D/L Ratio), Fluid SP Amphetamines (D/L Ratio), Serum/Plasma U Amphetamines (D/L Ratio), Urine B Amphetamines Screen, Blood 80101x FL Amphetamines Screen, Fluid 80101x SP Amphetamines Screen, Serum/Plasma 80101x U Amphetamines Screen, Urine 80101x SP Armodafinil, Serum/Plasma B Anticoagulant Poisoning Panel (Qualitative), Blood Page 3 of 154
4 0406SP Anticoagulant Poisoning Panel (Qualitative), Serum/Plasma 0406TI Anticoagulant Poisoning Panel (Qualitative), Tissue 83788, SP Brodifacoum (Qualitative), Serum/Plasma SP Bromadiolone (Qualitative), Serum/Plasma SP Chlorophacinone (Qualitative), Serum/Plasma SP Dicumarol (Qualitative), Serum/Plasma SP Difenacoum (Qualitative), Serum/Plasma SP Diphacinone (Qualitative), Serum/Plasma SP Warfarin (Qualitative), Serum/Plasma B Antipyrine, Blood SP Antipyrine, Serum/Plasma U Aromatic Solvents Metabolites Panel 2, Urine 82570, 84600, , 84600, SP Apixaban, Serum/Plasma 0450SP Aprobarbital, Serum/Plasma U Aprobarbital, Urine B Aripiprazole, Blood SP Aripiprazole, Serum/Plasma U Aromatic Solvents Panel, Urine 82570, 84600, 83789, , 84600, 83921x2 0474SP Asenapine, Serum/Plasma B Atenolol, Blood 0483FL Atenolol, Fluid 0483SP Atenolol, Serum/Plasma 0483TI Atenolol, Tissue 83789, U Atenolol, Urine 0486B Atomoxetine, Blood SP Atomoxetine, Serum/Plasma U Atomoxetine, Urine SP Atovaquone, Serum/Plasma B Atropine, Blood SP Atropine, Serum/Plasma U Atropine, Urine B Avanafil, Blood 0495SP Avanafil, Serum/Plasma 0498B Bactrim, Blood 84311, x2 0498SP Bactrim, Serum/Plasma 84311, x2 Page 4 of 154
5 0500B Barbital, Blood SP Barbital, Serum/Plasma U Barbital, Urine SP Bedaquiline, Serum/Plasma 0512B Barbiturates Screen, Blood SP Barbiturates Screen, Serum/Plasma TI Barbiturates Screen, Tissue 80101, U Barbiturates Screen, Urine B Belladonna Alkaloids Panel, Blood FL Belladonna Alkaloids Panel, Fluid SP Belladonna Alkaloids Panel, Serum/Plasma U Belladonna Alkaloids Panel, Urine U Bentiromide PABA Test, Urine B Benzaldehyde, Blood P Benzocaine, Plasma U Benzocaine, Urine B Benzodiazepines Screen, Blood FL Benzodiazepines Screen, Fluid SP Benzodiazepines Screen, Serum/Plasma TI Benzodiazepines Screen, Tissue 80101, U Benzodiazepines Screen, Urine B Benzonatate, Blood FL Benzonatate, Fluid SP Benzonatate, Serum/Plasma U Benzonatate, Urine B Cocaine and Metabolites Screen, Blood FL Cocaine and Metabolites Screen, Fluid SP Cocaine and Metabolites Screen, Serum/Plasma TI Cocaine and Metabolites Screen, Tissue 80101, U Cocaine and Metabolites Screen, Urine B Benzphetamine as Metabolites, Blood SP Benzphetamine as Metabolites, Serum/Plasma U Benzphetamine as Metabolites, Urine , B Benztropine, Blood 0620FL Benztropine, Fluid 0620SP Benztropine, Serum/Plasma 0620TI Benztropine, Tissue 83789, Page 5 of 154
6 0620U Benztropine, Urine 0641B Sotalol, Blood 0641SP Sotalol, Serum/Plasma 0649SP Methotrexate, Serum/Plasma 0650B Biperiden, Blood SP Biperiden, Serum/Plasma B Bretylium, Blood SP Bretylium, Serum/Plasma U Bretylium, Urine SP Bromocriptine, Serum/Plasma 0770B Brompheniramine, Blood SP Brompheniramine, Serum/Plasma U Brompheniramine, Urine SP Budesonide, Serum/Plasma 0796B Bumetanide, Blood 0796SP Bumetanide, Serum/Plasma 0800B Bupivacaine, Blood FL Bupivacaine, Fluid SP Bupivacaine, Serum/Plasma TI Bupivacaine, Tissue 82491, U Bupivacaine, Urine B Buprenorphine and Metabolite Free (Unconjugated), Blood SP 0801U 0802B 0802SP Buprenorphine and Metabolite Free (Unconjugated), Serum/Plasma Buprenorphine and Metabolite Total (Conjugated/Unconjugated), Urine Buprenorphine and Metabolite Free (Unconjugated) Screen, Blood Buprenorphine and Metabolite Free (Unconjugated) Screen, Serum/Plasma U Buprenorphine Screen, Urine B Bupropion and Metabolite, Blood FL Bupropion and Metabolite, Fluid SP Bupropion and Metabolite, Serum/Plasma TI Bupropion and Metabolite, Tissue 83789, U Bupropion and Metabolite, Urine Page 6 of 154
7 0805B Buspirone, Blood 0805SP Buspirone, Serum/Plasma 0805U Buspirone, Urine 0810B Butabarbital, Blood SP Butabarbital, Serum/Plasma U Butabarbital, Urine SP Busulfan, Serum/Plasma 0830B Butalbital, Blood SP Butalbital, Serum/Plasma TI Butalbital, Tissue 82205, U Butalbital, Urine B Solvent Exposure Profile, Blood 84600x2, , 82441x2 0872U Solvent Profile, Urine 82570, 84600, 83789, 82441, 83921x , 84600, 82441, 83921x3 0885B Butorphanol Free (Unconjugated), Blood SP Butorphanol Free (Unconjugated), Serum/Plasma U Butorphanol Total (Conjugated/Unconjugated), Urine B Cannabinoids Panel, Blood FL Cannabinoids Panel, Fluid ME Cannabinoids Panel (Qualitative), Meconium 80100, SP Cannabinoids Panel, Serum/Plasma TI Cannabinoid Metabolite, Tissue 82542, B Cannabidiol, Blood SP Cannabidiol, Serum/Plasma U Cannabinoid Metabolite, Urine SP Carbamazepine and Metabolite Free/Bound, Serum/Plasma , SP Carbidopa, Serum/Plasma B Carbinoxamine, Blood U Carbon Disulfide Exposure (TTCA), Urine 82570, , SP Antidepressants Panel (SSRI/SNRI), Serum (CSA) , U Benzoylecgonine, Urine (CSA) U Benzodiazepines Panel, Urine (CSA) U Amphetamines Panel, Urine (CSA) SP Vitamin K, Serum/Plasma (CSA) SP Low Leflunomide Metabolite, Serum/Plasma (CSA) 1000B Carboxy, Met and Sulf Hemoglobin, Blood 82375, , 83060, Page 7 of 154
8 1033ST Cathartic Laxatives Profile, Stool 80103x2, 83735, 80375, B 10010U Drug Impaired Driving/DRE Custom Toxicology Panel, Blood (CSA) IN State Tox Lab Drug Impaired Driving/DRE Custom Toxicology Panel, Urine (CSA) IN State Tox Lab 80101x2, , x2, , SP Drugs of Abuse Screen (6 Panel), Serum/Plasma (CSA) 80101x U Ethyl Sulfate, Urine (CSA) SP Topiramate, Serum/Plasma (CSA) U Barbiturates, Urine (CSA) U Ethyl Glucuronide, Urine (CSA) U Opiates Total with 6 MAM Free (Qualitative), Urine (CSA) 83925x , 80365, 80356, 80361, U Ethyl Glucuronide and Ethyl Sulfate, Urine (CSA) 83789x x SP Lacosamide, Serum/Plasma (CSA) U Barbiturates Panel (Qualitative), Urine (CSA) OF Nicotine and Metabolite, Oral Fluid (Saliva) (CSA) B Drug Impaired Driving/DRE Custom Toxicology Panel, Blood (CSA) IN State Tox Lab 80101, , U 10025U Drug Impaired Driving/DRE Custom Toxicology Panel, Urine (CSA) IN State Tox Lab Synthetic Cannabinoid Metabolites (Qualitative), Urine (CSA) 80101, , SP Mirtazapine, Serum/Plasma (CSA) U Bath Salts Panel, Urine (CSA) B Carbon Monoxide Exposure Biouptake Screen, Blood B Amphetamines (Drug Impaired Driving DRE Toxicology), Blood (CSA) , SP 10032B 10032SP 10033B Amphetamines (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Barbiturates Panel (Drug Impaired Driving DRE Toxicology), Blood (CSA) Barbiturates Panel (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Benzodiazepines Panel (Drug Impaired Driving DRE Toxicology), Blood (CSA) , Page 8 of 154
9 10033SP Benzodiazepines Panel (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) 10034B 10034SP 10035B 10035SP 10036B 10036SP 10037B 10037SP 10038B 10038SP 10039B 10039SP 10040B 10040SP 10041B Cannabinoids Panel (Drug Impaired Driving DRE Toxicology), Blood (CSA) Cannabinoids Panel (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Carisoprodol and Metabolite (Drug Impaired Driving DRE Toxicology), Blood (CSA) Carisoprodol and Metabolite (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Cocaine and Metabolites (Drug Impaired Driving DRE Toxicology), Blood (CSA) Cocaine and Metabolites (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Fentanyl and Metabolite (Drug Impaired Driving DRE Toxicology), Blood (CSA) Fentanyl and Metabolite (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Methadone and Metabolite (Drug Impaired Driving DRE Toxicology), Blood (CSA) Methadone and Metabolite (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Opiates Free (Unconjugated) (Drug Impaired Driving DRE Toxicology), Blood (CSA) Opiates Free (Unconjugated) (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Zolpidem (Drug Impaired Driving DRE Toxicology), Blood (CSA) Zolpidem (Drug Impaired Driving DRE Toxicology), Serum/Plasma (CSA) Drug Impaired Driving/DRE Custom Toxicology Panel, Blood (CSA) NC SCL , 80361, , 80361, x2, , B Drugs of Abuse (8 Panel) Screen, Blood (CSA) 80101x U Postmortem Toxicology Urine Screen Add on (6 MAM 80101x Quantification only) (CSA) 10051B Postmortem Toxicology Basic with Vitreous Alcohol Confirmation, Blood (CSA) 82055, 80101x x2 Page 9 of 154
10 10052B Postmortem Toxicology Expanded with Vitreous 80100, 82055, 80301x2, Alcohol Confirmation, Blood (CSA) 80101x U GC/MS Drug Screen, Urine (CSA) 80100x x SP Drug Panel (Qualitative), Serum/Plasma (CSA) 80194, 83788x7, 82541, 83840, 80156, 83789, 82486x5, 80184x , 80338x2, 80194, 80358, 80185, 80173, 80332, 80335, 80156, 80184, 80332x3, B Postmortem Toxicology Basic, Blood (CSA) 82055, 80101x x U Drug Panel Creatinine Corrected, Urine (CSA) 83925x2, 82570, , 82570, 80358, 80361, B Carbon Monoxide Profile, Blood UH Cortisol, Urine (CSA) , SP Perfluorooctanoic Acid (Low Level), Serum/Plasma (CSA) U Buprenorphine (Qualitative), Urine (CSA) U Fentanyl and Metabolite, Urine (CSA) SP Drugs of Abuse Screen 9, Serum/Plasma (CSA) 80101x SP Drugs of Abuse Screen 9 (Qualitative), Serum/Plasma (CSA) 80101x B Postmortem Toxicology Expert with Vitreous Alcohol Confirmation, Blood (CSA) 80100x2, 82055, 80101x7 1009B Carbon Monoxide Exposure, Blood B Carbon Tetrachloride, Blood SP Carbon Tetrachloride, Serum/Plasma U Carbon Tetrachloride, Urine B Carbrital Profile, Blood 82491, SP Carbrital Profile, Serum/Plasma 82491, B Carisoprodol and Metabolite, Blood FL Carisoprodol and Metabolite, Fluid SP Carisoprodol and Metabolite, Serum/Plasma TI Carisoprodol and Metabolite, Tissue 82542, U Carisoprodol and Metabolite, Urine B Cetirizine, Blood 1040SP Cetirizine, Serum/Plasma 1040U Cetirizine, Urine 1050SP Chloramphenicol, Serum/Plasma B Celecoxib, Blood x2, 80304x2 Page 10 of 154
11 1055SP Celecoxib, Serum/Plasma U Celecoxib, Urine B Chlorcyclizine, Blood B Chlordiazepoxide and Metabolite, Blood SP Chlordiazepoxide and Metabolite, Serum/Plasma U Chlordiazepoxide and Metabolite, Urine B Chloroform, Blood SP Chloroform, Serum/Plasma B meta Chlorophenylpiperazine (mcpp), Blood SP meta Chlorophenylpiperazine (mcpp), Serum/Plasma U meta Chlorophenylpiperazine (mcpp), Urine B Chloroquine, Blood 1140FL Chloroquine, Fluid 1140P Chloroquine, Plasma 1140U Chloroquine, Urine 1180B Chlorothiazide, Blood 1180SP Chlorothiazide, Serum/Plasma 1190B Chlorpheniramine, Blood 1190SP Chlorpheniramine, Serum/Plasma 1190TI Chlorpheniramine, Tissue 83789, U Chlorpheniramine, Urine 1210B Chlorpromazine, Blood FL Chlorpromazine, Fluid SP Chlorpromazine, Serum/Plasma TI Chlorpromazine, Tissue 84022, U Chlorpromazine, Urine B Chlorpropamide, Blood SP Chlorpropamide, Serum/Plasma U Chlorpropamide, Urine B Chlorthalidone, Blood 1250SP Chlorthalidone, Serum/Plasma 1255B Chlorzoxazone, Blood SP Chlorzoxazone, Serum/Plasma U Chlorzoxazone, Urine Page 11 of 154
12 1262B Cimetidine, Blood SP Cimetidine, Serum/Plasma U Cimetidine, Urine B Clemastine, Blood SP Clemastine, Serum/Plasma B Clobazam, Blood SP Clobazam, Serum/Plasma U Clobazam, Urine B Clomipramine and Metabolite, Blood SP Clomipramine and Metabolite, Serum/Plasma TI Clomipramine and Metabolite, Tissue 82492, U Clomipramine and Metabolite, Urine B Clonazepam and Metabolite, Blood FL Clonazepam and Metabolite, Fluid SP Clonazepam and Metabolite, Serum/Plasma TI Clonazepam and Metabolite, Tissue 80154, U Clonazepam and Metabolite, Urine B Citalopram, Blood FL Citalopram, Fluid SP Citalopram, Serum/Plasma TI Citalopram, Tissue 83789, U Citalopram, Urine B Clonidine, Blood 1275FL Clonidine, Fluid 1275SP Clonidine, Serum/Plasma 1275TI Clonidine, Tissue 83789, U Clonidine, Urine 1280B Clorazepate as Metabolite, Blood SP Clorazepate as Metabolite, Serum/Plasma U Clorazepate as Metabolite, Urine B Cocaine and Metabolites, Blood FL Cocaine and Metabolites, Fluid H Cocaine and Metabolites (Qualitative), Hair 82520, 80101, 80301, x2 1300ME Cocaine and Metabolites (Qualitative), Meconium 80100, SP Cocaine and Metabolites, Serum/Plasma TI Cocaine and Metabolites, Tissue 82520, Page 12 of 154
13 1300U Cocaine and Metabolites, Urine B Cocaine and Products Panel, Blood SP Cocaine and Products Panel, Serum/Plasma U Cocaine and Products Panel, Urine U Codeine Total (Conjugated/Unconjugated) Screen, Urine B Colchicine, Blood 1320SP Colchicine, Serum/Plasma 1320U Colchicine, Urine 1342B Coricidin, Blood 82003, , SP Coricidin, Serum/Plasma 82003, , U Coricidin, Urine 82003, , B Cyclizine, Blood B Cyclobenzaprine, Blood FL Cyclobenzaprine, Fluid SP Cyclobenzaprine, Serum/Plasma TI Cyclobenzaprine, Tissue 83789, U Cyclobenzaprine, Urine B Cyproheptadine, Blood SP Cyproheptadine, Serum/Plasma U Cyproheptadine, Urine SP Dantrolene, Serum/Plasma B Dapsone and Metabolite, Blood SP Dapsone and Metabolite, Serum/Plasma B Darvocet, Blood 82542, , SP Darvocet, Serum/Plasma 82542, , U Darvocet, Urine 82542, , SP Dabigatran, Serum/Plasma 1450SP 1452B 1452U Drug Facilitated Sexual Assault Screen, Serum/Plasma Drug Facilitated Sexual Assault Survey 2, Blood Drug Facilitated Sexual Assault Survey 2, Urine 80100x4, 80154, 82055, 80101x x4, 80154, 82055, 80101x , 80100x4, 80154, 82055, 80101x4 1475SP Dechlorane, Serum/Plasma B Desipramine, Blood , 80301x2, 80304x , 80301x2, 80304x , 80301x3, 80304x4 Page 13 of 154
14 1490SP Desipramine, Serum/Plasma U Desipramine, Urine B Desvenlafaxine, Blood FL Desvenlafaxine, Fluid SP Desvenlafaxine, Serum/Plasma TI Desvenlafaxine, Tissue 83789, U Desvenlafaxine, Urine B Desomorphine, Blood SP Desomorphine, Serum/Plasma B Diazepam and Metabolites, Blood SP Diazepam and Metabolites, Serum/Plasma TI Diazepam and Metabolites, Tissue 80154, SP Diazepam and Metabolites, Serum/Plasma (CSA) B Diazoxide, Blood 1515SP Diazoxide, Serum/Plasma 1546B Dichlorobenzenes, Blood SP Dichlorobenzenes, Serum/Plasma B Dichloroethane, Blood SP Dichloroethane, Serum/Plasma U Dichloroethane, Urine B Dichloromethane and Carboxyhemoglobin, Blood 84600, , B Dichloromethane, Blood SP Dichloromethane, Serum/Plasma U Dichloromethane, Urine B Diclofenac, Blood SP Diclofenac, Serum/Plasma U Diclofenac, Urine B Dicumarol, Blood SP Dicumarol, Serum/Plasma B Dicyclomine, Blood SP Dicyclomine, Serum/Plasma U Dicyclomine, Urine B Diethylpropion, Blood SP Diethylpropion, Serum/Plasma U Diethylpropion, Urine B Diflunisal, Blood SP Diflunisal, Serum/Plasma Page 14 of 154
15 1611B Tetrafluoroethane and Difluoroethane Panel, Blood SP Digitoxin, Serum/Plasma B Diltiazem, Blood 1640SP Diltiazem, Serum/Plasma 1640TI Diltiazem, Tissue 83789, U Diltiazem, Urine 1683SP Dimethadione, Serum/Plasma B Dimethyltryptamine, Blood SP Dimethyltryptamine, Serum/Plasma U Dimethyltryptamine, Urine B Diphenhydramine, Blood 1760FL Diphenhydramine, Fluid 1760SP Diphenhydramine, Serum/Plasma 1760TI Diphenhydramine, Tissue 83789, U Diphenhydramine, Urine 1770B Diphenoxylate, Blood SP Diphenoxylate, Serum/Plasma U Diphenoxylate, Urine B Dipyridamole, Blood SP Dipyridamole, Serum/Plasma U Dipyridamole, Urine SP Acetaminophen, Serum/Plasma SP Diuretics Panel, Serum/Plasma 1809B Doxapram, Blood SP Doxapram, Serum/Plasma B Doxepin and Metabolite, Blood FL Doxepin and Metabolite, Fluid SP Doxepin and Metabolite, Serum/Plasma TI Doxepin and Metabolite, Tissue 80166, U Doxepin and Metabolite, Urine B Donepezil, Blood 1812FL Donepezil, Fluid 1812SP Donepezil, Serum/Plasma 1812TI Donepezil, Tissue 83789, B Doxazosin, Blood SP Doxazosin, Serum/Plasma U Doxazosin, Urine Page 15 of 154
16 1817B Doxylamine, Blood FL Doxylamine, Fluid SP Doxylamine, Serum/Plasma TI Doxylamine, Tissue 82491, U Doxylamine, Urine SP Dronabinol, Serum/Plasma B Dronedarone, Blood 1828SP Dronedarone, Serum/Plasma 1830B Droperidol, Blood SP Droperidol, Serum/Plasma U Droperidol, Urine SP Drugs of Abuse Screen (11 Panel), Serum/Plasma (CSA) 80101x B Drugs of Abuse (11 Panel) and Alcohol Screen, Blood 82055, 80101x x2 1858FL Drugs of Abuse (11 Panel) and Alcohol Screen, Fluid 82055, 80101x x2 1858SP Drugs of Abuse (11 Panel) and Alcohol Screen, Serum/Plasma 82055, 80101x x2 1858TI Drugs of Abuse (11 Panel) and Alcohol Screen, Tissue 82055, 80103x2, 80301x x U Drugs of Abuse (10 Panel) and Alcohol Screen, Urine 80101x10, x2 1861B Drugs of Abuse Screen (7 Panel), Blood 80101x U Drugs of Abuse Screen (6 Panel), Urine 80101x B Drugs of Abuse Screen (11 Panel), Blood 80101x FL Drugs of Abuse Screen (11 Panel), Fluid 80101x ME Drugs of Abuse Screen (10 Panel), Meconium 80101x10, SP Drugs of Abuse Screen (11 Panel), Serum/Plasma 80101x TI Drugs of Abuse Screen (11 Panel), Tissue 80101x11, U Drugs of Abuse Screen (10 Panel), Urine 80101x B Drug Screen (11 Panel), Blood 80101x U Drug Screen (10 Panel), Urine 80101x B Drug Screen Expanded, Blood 80100, 80101x , FL Drug Screen Expanded, Fluid 80100x x2 1876SP Drug Screen Expanded, Serum/Plasma 80100, 80101x , U Drug Screen Expanded, Urine 80101x2, 80101, 80301, 80304, B Dyazide, Blood 1900SP Dyazide, Serum/Plasma 1902B Duexis, Blood 82491x , SP Duexis, Serum/Plasma 82491x , Page 16 of 154
17 1905B Dothiepin, Blood B Dyphylline, Blood SP Dyphylline, Serum/Plasma U Dyphylline, Urine SP Entacapone and Tolcapone, Serum/Plasma SP Entacapone, Serum/Plasma SP Exemestane, Serum/Plasma 1950B Ephedrine, Blood SP Ephedrine, Serum/Plasma U Ephedrine, Urine U Esgic, Urine 80155, 82003, , 80329, B Ergotamine, Blood SP Ergotamine, Serum/Plasma U Ergotamine, Urine SP Ethacrynic Acid, Serum/Plasma U Ethacrynic Acid, Urine B Estazolam, Blood SP Estazolam, Serum/Plasma U Estazolam, Urine SP Ethambutol, Serum/Plasma 1965B Escitalopram, Blood FL Escitalopram, Fluid SP Escitalopram, Serum/Plasma U Escitalopram, Urine B Eszopiclone/Zopiclone, Blood SP Eszopiclone/Zopiclone, Serum/Plasma TI Eszopiclone/Zopiclone, Tissue 83789, U Eszopiclone/Zopiclone, Urine SP Ethchlorvynol, Serum/Plasma U Ethchlorvynol Overdose, Urine B Ethinamate, Blood SP Ethinamate, Serum/Plasma B Ethotoin, Blood SP Ethotoin, Serum/Plasma SP Eplerenone, Serum/Plasma 2053U 2 Butoxyethanol Occupational Exposure Monitoring, Urine 82542, , Page 17 of 154
18 2054U Ethylene Glycol Monomethyl Ether, Urine 82542, , U Ethylene Glycol Monoethyl Ether, Urine 82542, , B Etomidate, Blood P Etomidate, Plasma SP Ethylmorphine, Serum/Plasma B Etodolac, Blood SP Etodolac, Serum/Plasma U Etodolac, Urine B Famotidine, Blood SP Famotidine, Serum/Plasma B Felbamate, Blood SP Felbamate, Serum/Plasma U Felbamate, Urine SP Felodipine, Serum/Plasma B Fexofenadine, Blood 2073SP Fexofenadine, Serum/Plasma 2075B Fioricet, Blood 80155, 82003, , 80329, FL Fioricet, Fluid 80155, 82003, , 80329, SP Fioricet, Serum/Plasma 80155, 82003, , 80329, TI Fioricet, Tissue 80155, 82003, 82205, 80155, 80329, x3 2075U Fioricet, Urine 80155, 82003, , 80329, SP Famciclovir as Metabolite, Serum/Plasma 2079B Fentanyl and Metabolite, Blood FL Fentanyl and Metabolite, Fluid SP Fentanyl and Metabolite, Serum/Plasma TI Fentanyl and Metabolite, Tissue 83925, U Fentanyl and Metabolite, Urine B Fenfluramine and Metabolite, Blood U Ethyl Glucuronide, Urine SP Fenoprofen, Serum/Plasma SP Flucytosine, Serum/Plasma 2087B Fiorinal, Blood 80155, 80196, , 80329, U Fiorinal, Urine 80155, 80196, , 80329, B Flecainide, Blood SP Flecainide, Serum/Plasma U Flecainide, Urine Page 18 of 154
19 2089B Fluconazole, Blood 2089SP Fluconazole, Serum/Plasma 2095SP Flurbiprofen, Serum/Plasma U Flurbiprofen, Urine B Fluoxetine and Metabolite, Blood FL Fluoxetine and Metabolite, Fluid SP Fluoxetine and Metabolite, Serum/Plasma TI Fluoxetine and Metabolite, Tissue 82542, U Fluoxetine and Metabolite, Urine B Fluphenazine, Blood B Baclofen, Blood FL Baclofen, Fluid SP Baclofen, Serum/Plasma U Baclofen, Urine SP Fluphenazine, Serum/Plasma B Flurazepam and Metabolites, Blood SP Flurazepam and Metabolites, Serum/Plasma U Flurazepam as Metabolites, Urine B Fluvoxamine, Blood FL Fluvoxamine, Fluid SP Fluvoxamine, Serum/Plasma U Fluvoxamine, Urine B Petroleum Distillates Panel, Blood x2 2139FL Petroleum Distillates Panel, Fluid x2 2139TI Petroleum Distillates Panel, Tissue x2 2140B Furosemide, Blood 2140SP Furosemide, Serum/Plasma 2140U Furosemide, Urine 2143U Gabapentin, Urine B Galantamine, Blood 2148SP Galantamine, Serum/Plasma 2154SP Ganciclovir, Serum/Plasma 2154U Ganciclovir, Urine 2158B Glipizide, Blood SP Glipizide, Serum/Plasma U Glipizide, Urine B Glutethimide, Blood Page 19 of 154
20 2160SP Glutethimide, Serum/Plasma B Ganciclovir, Blood 2163B Glyburide, Blood SP Glyburide, Serum/Plasma B Gemfibrozil, Blood SP Gemfibrozil, Serum/Plasma B Gold, Blood FL Gold, Fluid SP Gold, Serum/Plasma U Gold, Urine SP Griseofulvin, Serum/Plasma 2185B Guaifenesin, Blood FL Guaifenesin, Fluid SP Guaifenesin, Serum/Plasma U Guaifenesin, Urine B Guanfacine, Blood 2186SP Guanfacine, Serum/Plasma 2186U Guanfacine, Urine 2198SP Halazepam as Metabolite, Serum/Plasma B Halocarbons Panel, Blood SP Halocarbons Panel, Serum/Plasma TI Halocarbons Panel, Tissue 84600, U Halocarbons Panel, Urine B Chlorinated Hydrocarbons, Blood (CSA) 84600, x2 2220B Haloperidol, Blood SP Haloperidol, Serum/Plasma TI Haloperidol, Tissue 83789, B Heroin Metabolites Free (Unconjugated), Blood , SP Heroin Metabolites Free (Unconjugated), Serum/Plasma , U Heroin Metabolites Free (Unconjugated), Urine , SP Hexobarbital, Serum/Plasma B Hydralazine, Blood SP Hydralazine, Serum/Plasma U Hydralazine, Urine SP Hydrastine, Serum/Plasma B Hydrochlorothiazide, Blood Page 20 of 154
21 2330SP Hydrochlorothiazide, Serum/Plasma 2330U Hydrochlorothiazide, Urine 2340B Hydrocodone Free (Unconjugated), Blood FL Hydrocodone Free (Unconjugated), Fluid SP Hydrocodone Free (Unconjugated), Serum/Plasma B Hydroflumethiazide, Blood 2345SP Hydroflumethiazide, Serum/Plasma 2362B Hydroxychloroquine, Blood 2362FL Hydroxychloroquine, Fluid 2362SP Hydroxychloroquine, Serum/Plasma 2362TI Hydroxychloroquine, Tissue 83789, U Hydroxychloroquine, Urine 2365B Hydroxyzine and Metabolite, Blood 2365FL Hydroxyzine and Metabolite, Fluid 2365SP Hydroxyzine and Metabolite, Serum/Plasma 2365U Hydroxyzine and Metabolite, Urine 2369B Hyoscyamine, Blood 2369SP Hyoscyamine, Serum/Plasma 2369U Hyoscyamine, Urine 2390B Ibuprofen, Blood FL Ibuprofen, Fluid SP Ibuprofen, Serum/Plasma TI Ibuprofen, Tissue 82491, U Ibuprofen, Urine B Iloperidone, Blood SP Iloperidone, Serum/Plasma SP Indapamide, Serum/Plasma 2400B Imipramine and Metabolite, Blood FL Imipramine and Metabolite, Fluid SP Imipramine and Metabolite, Serum/Plasma TI Imipramine and Metabolite, Tissue 80174, U Imipramine and Metabolite, Urine B Immunosupressants Panel, Blood (CSA) , 80169, 80195, B Indomethacin, Blood SP Indomethacin, Serum/Plasma U Indomethacin, Urine Page 21 of 154
22 2417B Inhalant Intoxicants Profile, Blood 84600, , B Inhalants Panel, Blood 84600x3, , 84600x3 2425B Ipecac Use Markers Screen, Blood FL Ipecac Use Markers Screen, Fluid SP Ipecac Use Markers Screen, Serum/Plasma U Ipecac Use Markers Screen, Urine B Isocarboxazid (as Benzylhydrazine), Blood SP Isoniazid, Serum/Plasma 2445B Isopropanol and Acetone, Blood SP Isopropanol and Acetone, Serum/Plasma U Isopropanol and Acetone, Urine B Isotretinoin, Blood SP Isotretinoin, Serum/Plasma B Itraconazole, Blood 2460SP Itraconazole, Serum/Plasma 2478U Zolpidem and Metabolites, Urine B Ketamine and Metabolite, Blood FL Ketamine and Metabolite, Fluid SP Ketamine and Metabolite, Serum/Plasma TI Ketamine and Metabolite, Tissue 82542, U Ketamine and Metabolite, Urine B Ketorolac, Blood SP Ketorolac, Serum/Plasma TI Ketorolac, Tissue 82491, U Ketorolac, Urine B Zolpidem, Blood FL Zolpidem, Fluid SP Zolpidem, Serum/Plasma TI Zolpidem, Tissue 83789, B Ketoconazole, Blood 2485SP Ketoconazole, Serum/Plasma 2486B Ketoprofen, Blood SP Ketoprofen, Serum/Plasma B Labetalol, Blood 2488FL Labetalol, Fluid 2488SP Labetalol, Serum/Plasma 2499U Laxatives Panel (Qualitative), Urine Page 22 of 154
23 2501B Levamisole, Blood 2501FL Levamisole, Fluid 2501SP Levamisole, Serum/Plasma 2501U Levamisole, Urine 2504SP Levodopa, Serum/Plasma B Levorphanol Screen, Blood SP Levorphanol Screen, Serum/Plasma U Levorphanol Screen, Urine B Levocetirizine, Blood 2517SP Levocetirizine, Serum/Plasma 2523SP Leflunomide as Metabolite, Serum/Plasma (CSA) 2525B Loratadine and Metabolite, Blood SP Loratadine and Metabolite, Serum/Plasma U Loratadine and Metabolite, Urine B Lacosamide, Blood FL Lacosamide, Fluid 2527SP Lacosamide, Serum/Plasma U Lacosamide, Urine B Desloratadine, Blood U Desloratadine, Urine B Loperamide, Blood SP Loperamide, Serum/Plasma U Loperamide, Urine B Leflunomide as Metabolite (Therapeutic Drug Monitoring), Blood 2531SP 2532B 2532SP Leflunomide as Metabolite (Therapeutic Drug Monitoring), Serum/Plasma Leflunomide as Metabolite (Pre Pregnancy Monitoring), Blood Leflunomide as Metabolite (Pre Pregnancy Monitoring), Serum/Plasma 2535B Lorazepam, Blood FL Lorazepam, Fluid SP Lorazepam, Serum/Plasma TI Lorazepam, Tissue 80154, U Lorazepam, Urine B Loxapine, Blood Page 23 of 154
24 2538SP Loxapine, Serum/Plasma U Loxapine, Urine B LSD Trace Analysis, Blood FL LSD Trace Analysis, Fluid SP LSD Trace Analysis, Serum/Plasma TI LSD Trace Analysis, Tissue 83789, U LSD Trace Analysis, Urine B LSD Screen, Blood SP LSD Screen, Serum/Plasma U LSD Screen, Urine U LSD (Qualitative), Urine (CSA) B Lurasidone, Blood SP Lurasidone, Serum/Plasma B Maprotiline, Blood SP Maprotiline, Serum/Plasma U Maprotiline, Urine B Memantine, Blood 2581FL Memantine, Fluid 2581SP Memantine, Serum/Plasma 2584B Methylenedioxyamphetamine, Blood SP Methylenedioxyamphetamine, Serum/Plasma U Methylenedioxyamphetamine, Urine B Methylenedioxymethamphetamine and Metabolite, Blood FL 2585SP 2585TI 2585U Methylenedioxymethamphetamine and Metabolite, Fluid Methylenedioxymethamphetamine and Metabolite, Serum/Plasma Methylenedioxymethamphetamine and Metabolite, Tissue Methylenedioxymethamphetamine and Metabolite, Urine , , B MDPV Stimulant Designer Drug Test, Blood SP MDPV Stimulant Designer Drug Test, Serum/Plasma U MDPV Stimulant Designer Drug Test, Urine B Meclizine, Blood 2590SP Meclizine, Serum/Plasma Page 24 of 154
25 2595B Mefloquine, Blood 2595SP Mefloquine, Serum/Plasma 2604B Melatonin, Blood 2604FL Melatonin, Fluid 2604SP Melatonin, Serum/Plasma 2604U Melatonin, Urine 2610B Meperidine and Metabolite, Blood FL Meperidine and Metabolite, Fluid SP Meperidine and Metabolite, Serum/Plasma TI Meperidine and Metabolite, Tissue 83925, U Meperidine and Metabolite, Urine SP Mephenytoin and Metabolite, Serum/Plasma U Mephenytoin and Metabolite, Urine SP Mephenytoin and Metabolite, Serum/Plasma (CSA) B Bath Salts Panel, Blood 83789x x2 2626SP Bath Salts Panel, Serum/Plasma 83789x x2 2626U Bath Salts Panel, Urine 83789x x2 2630B Mephobarbital and Metabolite, Blood SP Mephobarbital and Metabolite, Serum/Plasma U Mephobarbital and Metabolite, Urine B Mepivacaine, Blood SP Mepivacaine, Serum/Plasma B Meprobamate, Blood SP Meprobamate, Serum/Plasma U Meprobamate, Urine B Mercaptopurine and Metabolites, Blood 2679B Mescaline, Blood SP Mescaline, Serum/Plasma U Mescaline, Urine B Mescaline Screen, Blood SP Mescaline Screen, Serum/Plasma U Mescaline Screen, Urine SP Mesoridazine, Serum/Plasma B Metaxalone, Blood SP Metaxalone, Serum/Plasma U Metaxalone, Urine B Metformin, Blood Page 25 of 154
26 2740FL Metformin, Fluid 2740SP Metformin, Serum/Plasma 2740U Metformin, Urine 2760ME Methadone and Metabolite (Qualitative), Meconium 80100, B Lisdexamfetamine as Metabolite, Blood SP Lisdexamfetamine as Metabolite, Serum/Plasma U Lisdexamfetamine as Metabolite, Urine B Methamphetamine and Metabolite, Blood FL Methamphetamine and Metabolite, Fluid SP Methamphetamine and Metabolite, Serum/Plasma TI Methamphetamine and Metabolite, Tissue 82145, U Methamphetamine and Metabolite, Urine B Methanol, Blood SP Methanol, Serum/Plasma U Methanol, Urine B Methanol, Blood FL Methanol, Fluid SP Methanol, Serum/Plasma U Methanol, Urine U Methanol Exposure Profile, Urine 84600, 82570, , 83921, SP Methanol Poisoning Profile, Serum/Plasma 83921, , SP Methapyrilene, Serum/Plasma B Methaqualone, Blood SP Methaqualone, Serum/Plasma U Methaqualone, Urine B Metharbital and Metabolite, Blood SP Metharbital and Metabolite, Serum/Plasma U Metharbital and Metabolite, Urine B Methazolamide, Blood SP Methazolamide, Serum/Plasma U Methazolamide, Urine B Methimazole, Blood SP Methimazole, Serum/Plasma U Methimazole, Urine B Methocarbamol, Blood FL Methocarbamol, Fluid SP Methocarbamol, Serum/Plasma Page 26 of 154
27 2900U Methocarbamol, Urine B Dextro/Levo Methorphan, Blood FL Dextro/Levo Methorphan, Fluid SP Dextro/Levo Methorphan, Serum/Plasma TI Dextro/Levo Methorphan, Tissue 82491, U Dextro/Levo Methorphan, Urine U Dextromethorphan and Metabolite Ratio, Urine B Methsuximide as Metabolite, Blood FL Methsuximide as Metabolite, Fluid SP Methsuximide as Metabolite, Serum/Plasma TI Methsuximide as Metabolite, Tissue 83858, SP Methyldopa, Serum/Plasma SP Methylephedrine, Serum/Plasma B Methotrimeprazine, Blood SP Methotrimeprazine, Serum/Plasma B Methylphenidate and Metabolite, Blood FL Methylphenidate and Metabolite, Fluid SP Methylphenidate and Metabolite, Serum/Plasma TI Methylphenidate and Metabolite, Tissue 83789, U Methylphenidate and Metabolite, Urine SP Methyprylon, Serum/Plasma B Metoclopramide, Blood SP Metoclopramide, Serum/Plasma U Metoclopramide, Urine B Metolazone, Blood 3042SP Metolazone, Serum/Plasma 3043B Metoprolol, Blood 3043FL Metoprolol, Fluid 3043SP Metoprolol, Serum/Plasma 3043U Metoprolol, Urine 3045B Modafinil, Blood SP Modafinil, Serum/Plasma U Modafinil, Urine B Metronidazole, Blood 3050SP Metronidazole, Serum/Plasma 3055B Mexiletine, Blood SP Mexiletine, Serum/Plasma Page 27 of 154
28 3057B Midazolam, Blood FL Midazolam, Fluid SP Midazolam, Serum/Plasma U Midazolam as Metabolite, Urine B Milnacipran, Blood SP Milnacipran, Serum/Plasma U Milnacipran, Urine B Minoxidil, Blood 3062SP Minoxidil, Serum/Plasma 3075B Mirtazapine, Blood SP Mirtazapine, Serum/Plasma U Mirtazapine, Urine U Mitragynine and Metabolite (Qualitative), Urine B Molindone, Blood SP Molindone, Serum/Plasma U Molindone, Urine B Morphine and Glucuronide Metabolites, Blood SP Morphine and Glucuronide Metabolites, Serum/Plasma SP Moricizine, Serum/Plasma U t,t Muconic Acid, Urine 82570, , U Benzene Metabolites Panel, Urine 82570, , B Nadolol, Blood 3103SP Nadolol, Serum/Plasma 3103U Nadolol, Urine 3107B Nabumetone as Metabolite, Blood SP Nabumetone as Metabolite, Serum/Plasma U Nabumetone as Metabolite, Urine B Nalbuphine Free (Unconjugated), Blood SP Nalbuphine Free (Unconjugated), Serum/Plasma U Nalbuphine Total (Conjugated/Unconjugated), Urine B Naloxone Free (Unconjugated), Blood SP Naloxone Free (Unconjugated), Serum/Plasma U Naloxone Total (Conjugated/Unconjugated), Urine U Naloxone Total (Conjugated/Unconjugated) Screen, Urine Page 28 of 154
29 3116B Naltrexone and Metabolite Free (Unconjugated), Blood 3116SP 3116U Naltrexone and Metabolite Free (Unconjugated), Serum/Plasma Naltrexone and Metabolite Total (Conjugated/Unconjugated), Urine B Naphthalene and Metabolite, Blood 84600x , SP Naphthalene and Metabolite, Serum/Plasma 84600x , U Naphthalene and Metabolite, Urine 84600x , B Naphthalene, Blood FL Naphthalene, Fluid SP Naphthalene, Serum/Plasma U Naphthalene, Urine B 1 Naphthol, Blood SP 1 Naphthol, Serum/Plasma U 1 Naphthol, Urine B Naproxen, Blood FL Naproxen, Fluid SP Naproxen, Serum/Plasma U Naproxen, Urine SP Vitamin K, Serum/Plasma SP Neostigmine, Serum/Plasma B Nicardipine, Blood SP Nicardipine, Serum/Plasma B NBOMe (Qualitative), Blood SP NBOMe (Qualitative), Serum/Plasma U NBOMe (Qualitative), Urine B Nefazodone, Blood SP Nefazodone, Serum/Plasma U Nefazodone, Urine B Nicotine and Metabolite, Blood FL Nicotine and Metabolite, Fluid SP Nicotine and Metabolite, Serum/Plasma TI Nicotine and Metabolite, Tissue 83887, U Nicotine and Metabolite with Anabasine, Urine U Cotinine and Anabasine from Secondary Exposure, Urine Page 29 of 154
30 3158B Nifedipine, Blood SP Nifedipine, Serum/Plasma TI Nifedipine, Tissue 82491, SP Nimodipine, Serum/Plasma B Nitrazepam and Metabolite, Blood SP Nitrazepam and Metabolite, Serum/Plasma U Nitrazepam and Metabolite, Urine B Nitrofurantoin, Blood SP Nitrofurantoin, Serum/Plasma U Nitrofurantoin, Urine B Nizatidine, Blood SP Nizatidine, Serum/Plasma U Nizatidine, Urine B Nordiazepam and Metabolite, Blood SP Nordiazepam and Metabolite, Serum/Plasma U Nordiazepam and Metabolite, Urine B Nortriptyline, Blood SP Nortriptyline, Serum/Plasma TI Nortriptyline, Tissue 80182, U Nortriptyline, Urine B Nonsteroidal Anti Inflammatory Drug Panel, Blood SP Nonsteroidal Anti Inflammatory Drug Panel, Serum/Plasma U Nonsteroidal Anti Inflammatory Drug Panel, Urine B Nuedexta, Blood 82491, , SP Nuedexta, Serum/Plasma 82491, , B Olanzapine, Blood FL Olanzapine, Fluid SP Olanzapine, Serum/Plasma TI Olanzapine, Tissue 82491, B Beta Blockers Panel, Blood SP Beta Blockers Panel, Serum/Plasma TI Beta Blockers Panel, Tissue 83789, U Beta Blockers Panel, Urine B Symbyax, Blood 82542, , SP Symbyax, Serum/Plasma 82542, , B Omeprazole, Blood Page 30 of 154
31 3232SP Omeprazole, Serum/Plasma B Opiates Screen, Blood 80101x FL Opiates Screen, Fluid 80101x SP Opiates Screen, Serum/Plasma 80101x TI Opiates Screen, Tissue 80101x2, U Opiates Screen, Urine 80101x B Opiates Free (Unconjugated), Blood 80101x2, , 80356, 80361, B Orphenadrine, Blood SP Orphenadrine, Serum/Plasma U Orphenadrine, Urine B Oxazepam, Blood SP Oxazepam, Serum/Plasma U Oxazepam, Urine B Oxybutynin, Blood SP Oxybutynin, Serum/Plasma U Oxybutynin, Urine B Oxycodone Free (Unconjugated), Blood FL Oxycodone Free (Unconjugated), Fluid SP Oxycodone Free (Unconjugated), Serum/Plasma B Oxaprozin, Blood SP Oxaprozin, Serum/Plasma SP Paclitaxel, Serum/Plasma B Papaverine, Blood SP Papaverine, Serum/Plasma B Paraldehyde and Metabolite, Blood SP Paraldehyde and Metabolite, Serum/Plasma U Paraldehyde and Metabolite, Urine SP Paramethadione, Serum/Plasma B Paroxetine, Blood FL Paroxetine, Fluid SP Paroxetine, Serum/Plasma TI Paroxetine, Tissue 83789, U Paroxetine, Urine B Pemoline, Blood SP Pemoline, Serum/Plasma U Pemoline, Urine Page 31 of 154
Toxicology CPT Code Changes for 2016
Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G
Tests Impacted by 2015 CPT Changes
Toxicology Changes for 2015 HPV Examples of Toxicology Panels Molecular Pathology, FISH and Anatomic Pathology 1 Toxicology Changes for 2015 80100 Test Code Dos Test Name 2015 2015 Medicare 5229 Drug Screen,
An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
The CPT code for Human papillomavirus (HPV) has changed from 87621 to 87624. This code (87624) covers testing for HPV High Risk genotypes.
January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) Coding Manual on an annual basis. For 2015, the AMA made several
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers Important Notes: Last Updated: May 11, 2015 Pharmacists must submit a claim on PharmaNet at the time of purchase to enable coverage.
MVP s Medicare Stars Ratings: High Risk Medications
MVP s Medicare Stars Ratings: High Risk Medications The Center for Medicare and Medicaid Services (CMS) uses the Star Rating System to evaluate Medicare Advantage health plans as well as their networks
DUI in Southern Ohio MATT 2006
DUI in Southern Ohio MATT 2006 Laureen J. Marinetti, M.S., Ph.D. Chief Toxicologist Montgomery County Coroner s s Office & Miami Valley Regional Crime Lab (MVRCL) Dayton, Ohio Region The MVRCL is a regional
Pharmacological Management of Dementia
Pharmacological Management of Dementia Christopher Sullivan Lead Clinical Pharmacist South and West Devon Devon Partnership Trust Overview Management of cognitive symptoms Management of non-cognitive symptoms
Drugs with Anticholinergic Activity
PL Detail-Document #271206 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER December 2011 Drugs with Anticholinergic
$4, 30-day $10, 90-day
$4 Prescriptions - Choose from hundreds of generic drugs and over the counter medications. Free Home Delivery Mailed right to your home Free shipping Prescription Program includes up to a 30-day supply
$10.00 PRESCRIPTION PROGRAM DETAILS
$10.00 PRESCRIPTION PROGRAM DETAILS 1. The $10.00 program applies only to certain generic drugs at commonly prescribed 90 day usage dosages. (See list). 2. The Program may change without notification and
Emit Drugs of Abuse Urine Assays Cross-Reactivity List. Answers for life.
Emit Drugs of Abuse Urine Assays Cross-Reactivity List Answers for life. Contents Emit II Plus Amphetamines...4 Emit II Plus Barbiturate...8 Emit II Plus Benzodiazepine... 12 Emit II Plus Cannabinoid...
2013 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS
Toxicology Program Trends 213 213 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS Overview and Background This report discusses trends in the toxicology program, as well as the number of toxicology
PREFERRED GENERIC DRUG LIST
These discount programs are NOT health insurance policies and are not intended as a substitute for insurance. The programs do not qualify as a minimum creditable coverage under Massachusetts law or where
612 Program Midtown Express Pharmacy
ALENDRONATE SOD TAB 35MG (max 1 per week) $37.00 $70.00 ALENDRONATE SOD TAB 70MG (max 1 per week) $37.00 $70.00 ALLOPURINOL TAB 100MG $20.00 $38.00 ALLOPURINOL TAB 300MG $20.00 $38.00 AMITRIPTYLINE TAB
Directory of Generic Medications Eligible for Rx Savings Program Flat Fees
Directory of Generic Medications Eligible for Rx Savings Program Flat Fees CONNECTICUT VERSION If you re already enrolled in the FREE* Rx Savings Program, use this guide to find your best choices. And,
Pharmacy Savings Program
Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications
2013 Annual Toxicology Report
213 Annual Toxicology Report Department of Justice Forensic Science Division Toxicology Department 2679 Palmer Street Missoula, MT 5988 DOJTOX@mt.gov Personnel Phil Kinsey Scott Larson Scott Schlueter
Oral Fluid Drug Testing March 23 rd, 2015
Oral Fluid Drug Testing March 23 rd, 2015 Drug Testing Options Breath Blood Meconium Vitreous Hair Sweat Urine Oral Drug Testing Options Oral Fluid and Blood and Breath Actual levels (immediate use, up
Generic Pharmacy Discount
Generic Pharmacy Discount 83 Park Place Blvd Suite 101 Clearwater, FL 33759 Fourth Quarter 2014 727.461.6044 800.314.0088 Pharmacies Generic Discount Program Information Enclosed information provided
Drug Classifications. Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine
Drug Classifications I. Autonomic nervous system drugs Cholinergic (parasympathetic) drugs Ex. Acetylcholine, bethanecol, neostigmine, guanidine Cholinergic blocking drugs Ex. Atropine, scopolamine Adrenergic
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
Urine drug screens. Screening Methods
Screening Methods Urine drug screens Urine drug screens are generally performed using either immunoassays or gas chromatography-mass spectrometry (GC-MS). 2 Immunoassay UDS contain specific antibodies
Drugs & driving: the place of medication reviews in improving safety for older road users. Dr Jenny Gowan
Drugs & driving: the place of medication reviews in improving safety for older road users Dr Jenny Gowan Consultant pharmacist, Northern & North East Valley Divisions of General Practice, Melbourne, Victoria,
Harmful Interactions: Mixing Alcohol with Medicines
Harmful Interactions: Mixing Alcohol with Medicines May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. May cause DROWSINESS. ALCOHOL may intensify
Early Morning Waking Excessively Orderly or Perfectionistic
COLLEGE OF MEDICINE Jacksonville 580 W 8 th St T-2 6 th Fl Ste 6005 6266 Dupont Station Ct Department of Psychiatry Jacksonville, FL 32209 Jacksonville, Fl 32217 Division of Adult Psychiatry Phone 904-383-1038
PREFERRED GENERIC DRUG LIST
ALLERGIES & COLD AND FLU Preferred generic drugs MARCH 2013 supply* for $5 supply* for $10 and $15 * The day supply is based upon the average dispensing patterns for the specific drug and strength. 90-
Retail Prescription Program Drug List
Retail Prescription Program Drug List Price Matters New Men s Health Category Convenience Free Home Delivery Our 4 prescriptions have saved our customers over 3 billion The program is available to everyone,
What Does the Drug Test Tell Us
What Does the Drug Test Tell Us QUALITATIVE TOXICOLOGY TESTING for CLINICAL MANAGEMENT of the PATIENT Background The qualitative drug test is often referred to as the drug screen - a misnomer Testing performed
Urine Drug Toxicology and Pain Management Testing. Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA
Urine Drug Toxicology and Pain Management Testing Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA Learning Objectives Describe what chronic pain is, who is affected and
Harmful Interactions: Mixing Alcohol with Medicines
Harmful Interactions: Mixing Alcohol with Medicines. ct. ESS effe SIN this ar ROW nsify a c se D ay inte perating m cau o May OHOL when hinery. ALC CARE us mac USE angero or d U.S. Department of Health
June 2016 Updated Crosswalk:
June 2016 Updated Crosswalk: 2016 HCPCS G0279 G6001 G6002 G6003 G6004 deleted f Radiology Coding BCBSNC currently considers this service investigational and will not cover either the HCPCS CPT s. Diagnostic
Look-Alike Drug Names with Recommended Tall Man Letters
FDA and ISMP Lists of Look-Alike Drug Names with Recommended Tall Man Letters Since 2008, ISMP has maintained a list of drug name pairs and trios with recommended, bolded tall man (uppercase) letters to
Members enjoy more Pharmacy savings *
Sam s Plus Members enjoy more Pharmacy savings 5 prescription drugs available for FREE Generic medications: Donepezil, Pioglitazone, Escitalopram, Finasteride and Vitamin D2 50,000IU are $ 0 for a 30-day
Indiana State Department of Toxicology 2012 Annual Report
Indiana State Department of Toxicology 2012 Annual Report Pictured on the cover is the State of Indiana Forensic and Health Sciences Laboratories facility housing the Indiana State Department of Toxicology.
Clinic Reference Guide
Clinic Reference Guide 2010 Alliance Toxicology LLC PO Box 5000, PMB 190 Rancho Santa Fe, CA 92067 AllianceToxicologyLLCprovidesclinicaldrugtestingservicesforphysicians.Our companyprovidesacomprehensivedrugtestingpanelwhichincludesover40
2015 CPT Code Changes ACL Test
Changes ACL Test Test Description UCOMP DRUG SCREEN COMPLETE 80100 80303 G0431 UDINV DRUG INVESTIGATION 80100 80303 G0431 UTLC THIN LAYER CHROMATOGRAPHY DRUG SCREEN 80100 80303 G0431 UNIC NICOTINE, URINE
Update on Drug Impaired Driving. WTSC Impaired Driver Conference SeaTac, December 2006
Update on Drug Impaired Driving WTSC Impaired Driver Conference SeaTac, December 2006 12/4/2007 Alcohol, Drugs and Driving Household Survey, 2004 (prior year) Any Illicit Drug Use 19.9 Million 8.3% Marijuana
TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10
AMBO PROJECT: ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES TRENDS IN ALCOHOL AND DRUG RELATED AMBULANCE ATTENDANCES IN MELBOURNE 2009 10 Belinda Lloyd ambo project: Alcohol and Drug Related Ambulance
Triage TOX Drug Screen Product Insert Rapid Qualitative simultaneous detection of drug and/or the major urinary metabolites of 10 different drug
Triage TOX Drug Screen Product Insert Rapid Qualitative simultaneous detection of drug and/or the major urinary metabolites of 10 different drug classes (11 unique assays). Product Insert Catalog#: 94400
Comprehensive LC/MS Analysis of Illicit and Pain Management Drugs, Including Their Metabolites, in Urine
Comprehensive LC/MS Analysis of Illicit and Pain Management Drugs, Including Their Metabolites, in Urine Application Note Authors Peter JW Stone and Kevin McCann Agilent Technologies, Inc. Santa Clara,
Measuring Generic Efficiency in Part D
Measuring in Part D Rates among Medicare Part D Generic efficiency rate is a measurement of the total number of prescrip=ons filled as a generic for products with a direct generic subs=tute within a therapeu=c
BRAIN INJURY MEDICATIONS by Daniel Gardner, M.D. (copyright 9/94, 8/98)
BRAIN INJURY MEDICATIONS by Daniel Gardner, M.D. (copyright 9/94, 8/98) (This article may be reprinted and distributed freely provided the text is unchanged and full attribution is given to the author.)
Appropriate utilization of drug tests for pain management patients
Appropriate utilization of drug tests for pain management patients Gwen McMillin, PhD, DABCC (CC, TC) Medical Director, Toxicology, ARUP Laboratories Associate Professor (clinical), University of Utah
PROFILE -V MEDTOXScan Drugs of Abuse Test System INSERT
PROFILE -V MEDTOXScan Drugs of Abuse Test System INSERT 1. INTENDED USE The PROFILE -V MEDTOXScan Drugs of Abuse Test System consists of the PROFILE -V MEDTOXScan Test Devices and the MEDTOXScan Reader.
DRUG DRIVING OFFENCES
DRUG DRIVING OFFENCES Taking drug can affect body and mind coordination that can significantly impair the ability to drive a motor vehicle. Road Traffic Ordinance (Cap 374) was amended in 2011 in order
Comparison of EMIT II, CEDIA and DPC RIA Assays for the Detection of Lysergic Acid Diethylamide in Forensic Urine Samples*
Journal of Analytical Toxicology, Vol, 26, October 2002 Comparison of EMIT II, CEDIA and DPC RIA Assays for the Detection of Lysergic Acid Diethylamide in Forensic Urine Samples* Russell F. Wiegand, Kevin
12629 LIBRIUM CHLORDIAZEPOXIDE HCL 12637 LIBRIUM CHLORDIAZEPOXIDE HCL 12645 LIBRIUM CHLORDIAZEPOXIDE HCL 13110 VALIUM DIAZEPAM 13277 VALIUM DIAZEPAM 24406 LITHANE LITHIUM CARBONATE 25836 SURMONTIL TRIMIPRAMINE
Each un coated tablet contains: Nimesulide. Each un coated tablet contains: Nimesulide Paracetamol
Sr No. Generic Name Composition Claim 1 Tabs. 100/ 2 + Para Tabs. 3 + Tizanidine Tabs. 4 + Tabs. 5 +Serratio Tabs. 6 +Serratio Tabs. 7 Aceclo Tabs. IP 8 Aceclo + Para Tabs. 9 Aceclo + Para + Chlorzoxazone
UnitedHealthcare Group Medicare Advantage (PPO)
Your Plan Explained UnitedHealthcare Group Medicare Advantage (PPO) UHEX11MP3230855_001 Y0066_100616_09113 Your Medicare. This brochure explains your Medicare Advantage plan, a type of health plan also
Formulary and OTC Alternative(s) 1-16* Recommendation 1 Antihypertensive Guanabenz Guanfacine Methyldopa Reserpine (>0.1mg/day)
High Risk Medications in Older Adults: Drug Alternative(s) Drug Class Drug Names Concern / Risk 1 Beers Formulary and OTC Alternative(s) 1-16* Recommendation 1 Antihypertensive Guanabenz Guanfacine Methyldopa
PtProtect Pain Medication Management Program Monitors Patient Compliance
PHYSICIAN UPDATE 2013 Edition PtProtect Pain Medication Management Program Monitors Patient Compliance The PtProtect (Patient Protect) program offers pain medication management panels designed to improve
Changes to CPT Coding for 2015
Changes to CPT Coding for 2015 The American Medical Association (AMA) publishes the Current Procedural Terminology (CPT) coding manual on an annual basis. For 2015, the pathology and laboratory section
The Application of Ultra-Fast Triple Quadrupole LC-MS/MS to Forensic Analysis. Abstract
SR14_008E S h i m a d z u R e v i e w The Application of Ultra-Fast Triple Quadrupole LC-MS/MS to Forensic Analysis by Toshikazu MINOHATA 1, Keiko KUDO 2, Kiyotaka USUI 3, Noriaki SHIMA 4, Munehiro KATAGI
Pain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients. Drug Benefit List. Updated February 15, 2016
BC Cancer Agency & Canadian Cancer Society Financial Support Drug Program (FSDP) for Cancer Patients Drug Benefit List Updated February 15, 2016 The FSDP will operate following rules established by the
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information
PSYCHOSOMATIC INSTITUTE OF SAN ANTONIO New Patient Information Name: Last: First: MI: Birth Date: Sex: M F Marital Status: Single Married Divorced Separated Widowed Partnered Other Preferred name: Emergency
. ก ก 1. Actifed tab/syr. Triprolidine : should be stored in tight, light-resistant Pseudoepedrine : Triprolidine (p.25) Pseudoepedrine (p.
ก ก. 2553 (p.807) 3. Adrenaline inj. 1mg/ml (Epinephrine inj.) ( Druginfor. p.629) 4. Aminophylline/ Theophylline inj. (Drug infor. Ed. 11 th p.1339) 5. Amlodipine + HCTZ (Moduretic). ก ก 1. Actifed tab/syr.
Use of High Risk Medications in the Elderly (DAE)
Use of High Risk Medications in the Elderly (DAE) Contents OVERVIEW... 1 TECHNICAL SPECIFICATIONS... 3 APPENDIX 1... 5 OVERVIEW Measure Description The percentage of patients 65 years of age and older
LC-MS for Pain Management Support. Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014
Arizona Department of Health Services/ Division of Behavioral Health Services Behavioral Health Drug List Effective 1/1/2014 The Arizona Department of Health Services, Division of Behavioral Health Services,
LC-MS for Pain Management Support
LC-MS for Pain Management Support Gwen McMillin, PhD, DABCC(CC,TC) University of Utah ARUP Laboratories Outline Overview of drug testing, as a component of the therapeutic plan, in the management of chronic
Oral Fluid as an alternative matrix in workplace drug testing: which drugs at which cutoff concentration?
Oral Fluid as an alternative matrix in workplace drug testing: which drugs at which cutoff concentration? Michael Böttcher MVZ Labor Dessau Gmb, Dessau, Germany a d d i c t i o n / a b u s e r e l e v
Psychiatric Medications: Pearls and Pitfalls. The majority of medications used in patients with psychiatric diagnoses have more than one use.
Psychiatric Medications: Pearls and Pitfalls Rule #1 The majority of medications used in patients with psychiatric diagnoses have more than one use. Without access to the patient s medical record, to review
Simultaneous Quantitation of 43 Drugs in Human Urine with a Dilute-and-Shoot LC-MS/MS Method
Simultaneous Quantitation of 4 Drugs in Human Urine with a Dilute-and-Shoot LC-MS/MS Method Xiang He and Marta Kozak, Thermo Fisher Scientific, San Jose, CA Application Note 76 Key Words TSQ Quantum Access
The 365-day period begins with the first dispensing transaction for each Ontario Drug Benefit (ODB) recipient on or after October 1, 2015.
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Chronic-use Medications List by In accordance with subsection 18 (11.1) of Ontario Regulation 201/96 made under the Ontario Drug Benefit
Amphetamines Assay 2 SUMMARY 3 METHODOLOGY 4 REAGENTS 1 INTENDED USE
2 SUMMARY August 2010 Catalog Quantity/ Number Product Description Volume OSR9C229 Emit II Plus Amphetamines Assay OSR9C618 R1 (Antibody/Substrate Reagent 1) OSR9C648 R2 (Enzyme Reagent 2) 2 x 33 ml 2
CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003
Page 1 ATTACHMENT C CITY OF MONTEREY Substance Abuse Policy General Employees of Monterey (GEM) July 1, 2003 PURPOSE This policy provides guidelines for the detection and deterrence of alcohol and drug
Clinical Drug Screening and/or Drug Testing
Manual: Policy Title: Reimbursement Policy Clinical Drug Screening and/or Drug Testing Section: Laboratory & Pathology Subsection: None Date of Origin: 10/26/2011 Policy Number: RPM016 Last Updated: 1/8/2016
Value-Priced Medication List
Value-Priced Medication List In addition to the discounts on thousands of brand-name and most other generic medications that Walgreens Prescription Savings Club members enjoy, club members receive greater
Cefadroxil and cefalexin safe to administer. Metronidazole, possibly tinidazole. Disulfiram-like effect (see disulfiram). Major changes in alcohol
Guidance on the administration of medicines to inpatients believed to have consumed alcohol Sussex Partnership NHS Trust clinical policy Alcohol, Harmful Substance and Illegal Drug Use by Service Users
Lamictal, lamotrigine Lithium, lithobid, eskalith Depakote, valproate Trileptal, oxcarbazepine Tegretol, equetro, carbamazepine Atypicals (aripiprazole, abilify, olanzapine, zyprexa, invega, risperdal,
Collection Instructions for ARUP Drug Screen Kit #49204
Collection Instructions for ARUP Drug Screen Kit #49204 Manufacturer Purpose of Kit / Reagent (tests) Kit / Reagent Contents (list components) Other Supplies Needed ARUP Laboratories For Point of Collection
SMART DISCHARGE. Client s Name: Client ID: Partial Hospitalization Clinically Managed Medium Intensity Residential Treatment
SMART DISCHARGE Client s Name: Client ID: DATE OF DISCHARGE: Reason for Discharge Completed Treatment no further treatment needed Completed Treatment Plan/Referred Incomplete Client Left Before Completing
Understanding Drug Screens & PharmCAS Drug Screening Program Overview. Suzi Arant, Senior Business Developer July 8, 2011
Understanding Drug Screens & PharmCAS Drug Screening Program Overview Suzi Arant, Senior Business Developer July 8, 2011 Presentation Overview Drug Screening in Healthcare Drug Screening Panels Drugs of
Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain (CNCP)
Appendix D: Urine Drug Testing for Monitoring Opioid Therapy i. Monitoring opioid therapy with urine drug testing (UDT) ii. UDT algorithm for monitoring opioid therapy iii. UDT clinical vignettes iv. Frequently
(Comprehensive list of covered drugs)
Standard Plan 015 Prescription Drug Formulary (Comprehensive list of covered drugs) +306$SSURYHG)RUPXODU\)LOH6XEPLVVLRQ,'9HUVLRQ1XPEHU16 This document contains information about the drugs we cover in this
The DRE DUI & DRUGS. Captain George Crum Fullerton Police Department
The DRE DUI & DRUGS Captain George Crum Fullerton Police Department What is a DRE? Drug Recognition Expert Experienced officer Selected by their department Special training in detecting drug influence/impairment
Members enjoy more Pharmacy savings *
Sam s Plus Members enjoy more Pharmacy savings 5 prescription drugs available for FREE Generic medications: Donepezil, Pioglitazone, Escitalopram, Finasteride and Vitamin D2 50,000IU are $ 0 for a 30-day
Updated MAR 26, 2013 Myelography Seizures:
Updated MAR 26, 2013 Myelography Medications to be evaluated prior to myelography. This list is to assist the radiologist, pharmacist, and radiology technologist in evaluating medication risk associated
Amy LaHood MD MPH FAAFP December 19, 2012
Amy LaHood MD MPH FAAFP December 19, 2012 Identify trends & consequences of the current opioid epidemic Review evidence & expert guidelines for prescribing controlled substances Identify challenges/solutions
Harmful Interactions
May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. Harmful Interactions mixing alcohol with medicines May cause DROWSINESS. ALCOHOL may intensify
EXCHANGES_CVSC_NY3 eff 10/01/2015
EXCHANGES_CVSC_NY3 eff 10/01/2015 Drug Name ADHD/ANTI-NARCOLEPSY/ANTI-OBESITY/ANOREXIANTS Amphetamines amphetamine-dextroamphetamine cap sr 1 QL (90 caps / 25 days) 24hr 5 amphetamine-dextroamphetamine
HealthyBlue Select Generics
Certain drugs are considered generic preventive by CareFirst BlueCross BlueShield and CareFirst BlueChoice, Inc. s Pharmacy Management Team. As a HealthyBlue CDH member, the drugs listed below are not
Simultaneous Quantitation of 78 Drugs and Metabolites in Urine with a Dilute-And-Shoot LC MS-MS Assay
Journal of Analytical Toxicology 2015;1 12 doi:10.1093/jat/bkv024 Journal of Analytical Toxicology Advance Access published April 1, 2015 Article Simultaneous Quantitation of 78 Drugs and Metabolites in
Harmful Interactions. mixing alcohol with medicines
Harmful Interactions mixing alcohol with medicines May cause DROWSINESS. ALCOHOL may intensify this effect. USE CARE when operating a car or dangerous machinery. Harmful interactions You ve probably seen
YOUR MEDICATIONS WHAT YOU SHOULD KNOW
YOUR MEDICATIONS WHAT YOU SHOULD KNOW A Handbook For People With Developmental Disabilities Developmental Disabilities Area Board 10 Developmental Disabilities Area Board 10 411 N. Central Avenue Suite
OU MEDICAL CENTER Human Resource Policy and Procedure Manual. Subject: Drug and Alcohol
OU MEDICAL CENTER Human Resource Policy and Procedure Manual Subject: Drug and Alcohol Section: HR 6-10 Page: 1 of 5 Origination Date: 6/2004 Revision Date: 2/2006, 9/2008, 7/2009 Coverage: All OUMC employees
Pharmacogenomics - Moving from the Paradigm of Typical to Individual in Your Practice. Bethany Reed, RN, MSN
Pharmacogenomics - Moving from the Paradigm of Typical to Individual in Your Practice Bethany Reed, RN, MSN 22nd Annual Northeast Regional Nurse Practitioner Conference May 6-8, 2015 DISCLOSURES There
PHARMACOTHERAPY UPDATE
PHARMACOTHERAPY UPDATE Benjamin Gross, Pharm D, BCPS, BCACP, BC ADM, CDE Associate Professor Director of Residency Programs Lipscomb University College of Pharmacy and Health Sciences 1 DISCLOSURE I DO
Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.
In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the
A Generic LC-MS Method for the Analysis of Multiple of Drug of Abuse Classes with the Thermo Scientific Exactive TM System
A Generic LC-MS Method for the Analysis of Multiple of Drug of Abuse Classes with the Thermo Scientific Exactive TM System Kent Johnson Fortes lab, Wilsonville Oregon List of drug of abuse candidates for
Prevalence of Prescription and Illicit Drugs in Pregnancy-Associated Non-natural Deaths of Florida Mothers, 1999 2005*
PAPER J Forensic Sci, November 2013, Vol. 58, No. 6 doi: 10.1111/1556-4029.12219 Available online at: onlinelibrary.wiley.com PATHOLOGY/BIOLOGY; TOXICOLOGY Nancy Hardt, 1 M.D.; Tit D. Wong, 2 M.P.H.; Martha
Toxicological Findings in 889 Fatally Injured Obese Pilots Involved in Aviation Accidents
Federal Aviation Administration DOT/FAA/AM-10/10 Office of Aerospace Medicine Washington, DC 20591 Toxicological Findings in 889 Fatally Injured Obese Pilots Involved in Aviation Accidents Sabra R. Botch
Medications Used in the Management of Disruptive Behavior Disorders
The following medication chart is provided as a brief guide to some of the medications used in the management of various behavior disorders, along with their potential benefits and possible side effects.
Direct antiviral therapy of hcv and relevant drug drug interactions for ivdu
Direct antiviral therapy of hcv and relevant interactions for ivdu Stefan Mauss Center for HIV and Hepatogastroenterology Duesseldorf, Germany Disclosures Advisory board: Abbvie, BMS, Boehringer Ingelheim,
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health
PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that
Results from the Swedish National Screening Programme 2010
REPORT Results from the Swedish National Screening Programme 2010 Jerker Fick, Richard H. Lindberg, Umeå University Lennart Kaj, Eva Brorström-Lundén, IVL B2014 December 2011 The report approved: 2011-12-16
Forensic Drug Detection. ELISA Test Kits Automated Equipment
Forensic Drug Detection ELISA Test Kits Automated Equipment Your Complete Forensic Drug Detection Source Neogen Corporation develops, manufactures, and markets a diverse line of products used to provide